(Q40433328)

20 September 2017

1 reference

title

Tumor heterogeneity and immunotherapy of cancer (English)

1 reference

20 September 2017

Tumor Heterogeneity and Immunotherapy of Cancer (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

30 May 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590832

30 May 2024

3

P. J. Kuppen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590832

30 May 2024

author name string

G. J. Fleuren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590832

30 May 2024

A. Gorter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590832

30 May 2024

S. Litvinov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590832

30 May 2024

S. O. Warnaar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590832

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590832

30 May 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00078.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00078.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

145

1 reference

20 September 2017

page(s)

91-122

1 reference

Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Post-thymectomy autoimmunity: abnormal T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The tumor marker CA 125 is a common constituent of normal cervical mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Somatic genetic changes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Nuclear structure and the three-dimensional organization of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Cell membrane-associated mucins and their adhesion-modulating property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The B7 and CD28 receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

T cell co-stimulation and in vivo tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

21 January 2018

The invasive phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Autoradiographic evaluation of monoclonal antibodies' access to melanoma-associated antigens in melanoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

T-cell immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

E-cadherin expression in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Role of NK cells in tumour growth and metastasis in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumours).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of major histocompatibility complex (MHC) antigens and their loss on culture in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

How does the extracellular matrix direct gene expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

From laminin to lamin: regulation of tissue-specific gene expression by the ECM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Cell interactions in alveolar macrophage-mediated suppression of the immune response: an unusual suppressor pathway involving a population of T-cells that express Lyt-1, L3T4, and I-J

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Carcinoembryonic antigen in primary and metastatic ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Nuclear DNA content of medullary thyroid carcinoma in a large family with the MEN-2A syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Tumor markers for ovarian cancer. A comparative immunohistochemical and immunocytochemical study of two commercial monoclonal antibodies (OV632 and OC125)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies: OV-TL 3/CD3 and OC/TR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of the adhesion molecules ICAM-1 and ICAM-2 on tumor cell lines does not correlate with their susceptibility to natural killer cell-mediated cytolysis: evidence for additional ligands for effector cell beta integrins

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis

30 May 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

30 May 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

30 May 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

MOv18 monoclonal antibody in diagnostic applications: capability to recognize the histotype of the original tumor

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Expression and function of CD59 on colonic adenocarcinoma cells

30 May 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas

30 May 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Tumor antigens recognized by T lymphocytes

30 May 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Relation between skin cancer and HLA antigens in renal-transplant recipients

30 May 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis

30 May 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients

30 May 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer

30 May 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The Concept of Immunological Surveillance

30 May 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro

30 May 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Can the HLA phenotype be used as a prognostic factor in breast carcinomas?

30 May 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

30 May 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience.

30 May 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications

30 May 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

A golden age for adhesion

30 May 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules

30 May 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes

30 May 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

30 May 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors

30 May 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

30 May 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies

30 May 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Differential effects of recombinant human leukocyte interferons on cell surface antigen expression

30 May 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis

30 May 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

30 May 2024

Tumor cell societies

73

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

30 May 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma

30 May 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

30 May 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

30 May 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis

30 May 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion

30 May 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats

30 May 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis

30 May 2024

97

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Cell cycle regulation of gene amplification

30 May 2024

99

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells

30 May 2024

101

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.

30 May 2024

105

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Anergic T cells as suppressor cells in vitro

30 May 2024

107

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The transforming growth factor-beta family

30 May 2024

110

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells.

30 May 2024

112

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Increased susceptibility of ifn-γ-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: Participation of ICAM-1 induction on target cells

30 May 2024

117

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Immunohistochemistry of Carcino-Embryonic Antigen in the Embryo, Fetus and Adult

30 May 2024

119

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Immunoregulatory effects of cytokines on natural killer cells

30 May 2024

120

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The clonal evolution of tumor cell populations

30 May 2024

123

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The value of immunohistochemistry for collagen IV expression in colorectal carcinomas

30 May 2024

124

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy

30 May 2024

125

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The biology of human germ cell tumours: retrospective speculations and new prospectives.

30 May 2024

126

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma

30 May 2024

127

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma

30 May 2024

128

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250

30 May 2024

129

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Target lysis by human lak cells is critically dependent upon target binding properties, but LFA-1, LFA-3 AND ICAM-1 are not the major adhesion ligands on targets

30 May 2024

131

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells

30 May 2024

133

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Tumor ploidy as a major prognostic factor in advanced ovarian cancer

30 May 2024

136

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The complement-inhibiting protein, Protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells

30 May 2024

137

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

30 May 2024

139

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms

30 May 2024

142

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

30 May 2024

143

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer

30 May 2024

145

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Prognostic factors in well-differentiated early-stage epithelial ovarian cancer

30 May 2024

146

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, DNA fingerprinting, and immunohistochemistry

30 May 2024

153

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Immunogenicity of melanoma-associated gangliosides in cancer patients

30 May 2024

155

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Unique combination of an ovarian gonadoblastoma, dysgerminoma, and mucinous cystadenoma in a patient with Turner's syndrome: a cytogenetic and molecular analysis

30 May 2024

162

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma

30 May 2024

164

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

The distribution of cellular adhesion molecules in pigmented skin lesions

30 May 2024

165

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen

30 May 2024

166

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.

30 May 2024

167

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity

30 May 2024

170

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

30 May 2024

175

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00078.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference